Circulation, Vol 60, 492-496, Copyright © 1979 by American Heart Association
LA Harker and W Hazzard
Studies of platelet and fibrinogen kinetics in 27 patients with
hyperlipoproteinemia and 28 control subjects demonstrated shortened
platelet survival and increased platelet turnover in seven patients with
type III and 10 patients with type IV-V hyperlipoproteinemia (p less than
0.01). There was no correlation between platelet survival time and specific
lipid levels, vascular disease, sex or age. Platelet kinetics were not
significantly altered from control values in eight patients with familial
hypercholesterolemia. Platelet aggregation studies and fibrinogen kinetic
measurements did not differ in any of the hyperlipoproteinemic groups of
patients from those in control subjects. Despite significant changes in
plasma lipids induced by clofibrate, platelet survival was significantly
extended only in patients with type IV-V hyperlipoproteinemia (p less than
0.05). These results are consistent with the hypothesis that atherogenesis
in patients with types III--V hyperlipoproteinemia may be associated with a
process of endothelial desquamation, and type IIa hyperlipoproteinemia may
involve nondesquamating endothelial injury.
ARTICLES
Platelet kinetic studies in patients with hyperlipoproteinemia: effects of clofibrate therapy
This article has been cited by other articles:
![]() |
M. L. Zucker, C. Trowbridge, J. Woodroof, S. B. Chernoff, L. Reynoso, and C. A. Dujovne Low- vs High-Dose Aspirin: Effects on Platelet Function in Hyperlipoproteinemic and Normal Subjects Arch Intern Med, May 1, 1986; 146(5): 921 - 925. [Abstract] [PDF] |
||||
![]() |
D. E. Hammerschmidt Platelets and the Environment JAMA, January 15, 1982; 247(3): 345 - 350. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1979 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |